中介细胞干细胞作为质瘤的治疗载体
Tomoya Oishi1, Shinichiro Koizumi1, Kazuhiko Kurozumi2
1Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Cancer gene therapy
|April 23, 2024
概括
介质细胞干细胞通过克服药物输送挑战,为质瘤治疗提供了一种有前途的方法. 这些细胞可以携带治疗剂穿过血脑屏障,增强抗瘤效果,以改善患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 由于血脑屏障和药物扩散不良,质瘤治疗面临重大挑战.
- 对于这种侵袭性脑瘤,迫切需要新的治疗策略.
研究的目的:
- 探索介质干细胞 (MSC) 作为质瘤治疗的输送载体的潜力.
- 审查基于MSC的策略,以改善药物透,基因疗法和结性病毒传递在质瘤中.
主要方法:
- 关于MSC在质瘤治疗中的应用现有文献的审查.
- 分析MSC的特性,包括血脑屏障的透,瘤细胞迁移和免疫耐受性.
- 评估MSC介导的化疗药物,自杀基因和瘤病毒的输送.
主要成果:
- 多重瘤细胞表现出穿越血脑屏障并向质瘤细胞的固有能力.
- 用MSC加载的化疗药物显示瘤透和积累的增强.
- 基于MSC的基因疗法和型病毒疗法显示出增加抗瘤疗效的潜力.
结论:
- 介质细胞干细胞代表了开发先进的质瘤疗法的有前途平台.
- 加强MSC向质瘤的迁移可以显著改善治疗剂的输送和抗瘤作用.
- 对质瘤中MSC功能和行为的进一步研究是有必要的,以优化患者的治疗策略.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


